229 related articles for article (PubMed ID: 35434847)
21. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Josephs KA; Duffy JR
Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
[TBL] [Abstract][Full Text] [Related]
22. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
[TBL] [Abstract][Full Text] [Related]
23. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
[TBL] [Abstract][Full Text] [Related]
24. [A 68-year-old man with speech disturbance as the initial symptom followed by bradykinesia and dementia. Clinical conference].
Tanaka R; Kobayashi T; Takanashi M; Tadokoro H; Mori H; Suda K; Kanazawa A; Mizuno Y
No To Shinkei; 2001 Jun; 53(6):585-97. PubMed ID: 11441873
[TBL] [Abstract][Full Text] [Related]
25. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
[TBL] [Abstract][Full Text] [Related]
26. [A 70-year-old man with a progressive gait disturbance and gaze palsy].
Nakamura T; Yoritaka A; Sumino S; Suzuki H; Mori H; Suda K; Takubo H; Mizuno Y
No To Shinkei; 1997 Jan; 49(1):93-100. PubMed ID: 9027910
[TBL] [Abstract][Full Text] [Related]
27. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
28. An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau.
Beck G; Yamashita R; Kido K; Ikenaka K; Chiba T; Yonenobu Y; Saito Y; Morii E; Hasegawa M; Murayama S; Mochizuki H
Neuropathology; 2023 Aug; 43(4):326-332. PubMed ID: 36593715
[TBL] [Abstract][Full Text] [Related]
29. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
[TBL] [Abstract][Full Text] [Related]
30. Discrepancy between clinical and pathological diagnoses of CBD and PSP.
Mizuno T; Shiga K; Nakata Y; Nagura J; Nakase T; Ueda Y; Takanashi Y; Urasaki K; Oyamada Y; Fushiki S; Nishikawa J; Yasuhara M; Nakajima K; Nakagawa M
J Neurol; 2005 Jun; 252(6):687-97. PubMed ID: 15754090
[TBL] [Abstract][Full Text] [Related]
31. Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.
Sitek EJ; Barczak A; Kluj-Kozłowska K; Kozłowski M; Narożańska E; Konkel A; Dąbrowska M; Barcikowska M; Sławek J
Neurol Neurochir Pol; 2015; 49(4):217-22. PubMed ID: 26188937
[TBL] [Abstract][Full Text] [Related]
32. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
[TBL] [Abstract][Full Text] [Related]
33. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.
Roemer SF; Grinberg LT; Crary JF; Seeley WW; McKee AC; Kovacs GG; Beach TG; Duyckaerts C; Ferrer IA; Gelpi E; Lee EB; Revesz T; White CL; Yoshida M; Pereira FL; Whitney K; Ghayal NB; Dickson DW
Acta Neuropathol; 2022 Oct; 144(4):603-614. PubMed ID: 35947184
[TBL] [Abstract][Full Text] [Related]
34. A case of atypical progressive supranuclear palsy.
Spaccavento S; Del Prete M; Craca A; Loverre A
Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
[TBL] [Abstract][Full Text] [Related]
35. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
[TBL] [Abstract][Full Text] [Related]
36. Can secondary degeneration accelerate the formation of neurofibrillary tangles? A case of hemispheric infarction showing asymmetric degeneration of the substantia nigra, red nuclei, inferior olivary nuclei and dentate nuclei with concomitant changes of progressive supranuclear palsy.
Matsumoto R; Oda M; Arai N; Shin T; Hayashi M
Acta Neuropathol; 1999 Feb; 97(2):208-14. PubMed ID: 9928834
[TBL] [Abstract][Full Text] [Related]
37. Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy.
Valentino RR; Koga S; Heckman MG; Brushaber DE; Diehl NN; Walton RL; Dickson DW; Ross OA
Mov Disord; 2020 May; 35(5):890-894. PubMed ID: 32142177
[TBL] [Abstract][Full Text] [Related]
38. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
Mimuro M; Yoshida M
Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
[TBL] [Abstract][Full Text] [Related]
39. Frontal dynamic aphasia in progressive supranuclear palsy: Distinguishing between generation and fluent sequencing of novel thoughts.
Robinson GA; Spooner D; Harrison WJ
Neuropsychologia; 2015 Oct; 77():62-75. PubMed ID: 26247320
[TBL] [Abstract][Full Text] [Related]
40. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia].
Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H
No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
